KR102032830B1 - Fuctional food improving skin condition comprising rice bran extract - Google Patents
Fuctional food improving skin condition comprising rice bran extract Download PDFInfo
- Publication number
- KR102032830B1 KR102032830B1 KR1020170139139A KR20170139139A KR102032830B1 KR 102032830 B1 KR102032830 B1 KR 102032830B1 KR 1020170139139 A KR1020170139139 A KR 1020170139139A KR 20170139139 A KR20170139139 A KR 20170139139A KR 102032830 B1 KR102032830 B1 KR 102032830B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- rice bran
- bran extract
- extract
- present
- Prior art date
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 132
- 235000009566 rice Nutrition 0.000 title claims abstract description 132
- 239000000284 extract Substances 0.000 title claims abstract description 107
- 235000013305 food Nutrition 0.000 title claims description 36
- 240000007594 Oryza sativa Species 0.000 title description 127
- 239000000203 mixture Substances 0.000 claims abstract description 56
- 230000037303 wrinkles Effects 0.000 claims abstract description 36
- 241000209094 Oryza Species 0.000 claims abstract 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 239000005018 casein Substances 0.000 claims description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 7
- 235000021240 caseins Nutrition 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 239000011732 tocopherol Substances 0.000 claims description 7
- 229960001295 tocopherol Drugs 0.000 claims description 7
- 229930003799 tocopherol Natural products 0.000 claims description 7
- 235000010384 tocopherol Nutrition 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims 1
- 230000006872 improvement Effects 0.000 abstract description 33
- 230000036541 health Effects 0.000 abstract description 24
- 235000013376 functional food Nutrition 0.000 abstract description 21
- 230000014509 gene expression Effects 0.000 abstract description 18
- 239000004480 active ingredient Substances 0.000 abstract description 16
- 239000002537 cosmetic Substances 0.000 abstract description 16
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 abstract description 13
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 abstract description 13
- 230000003020 moisturizing effect Effects 0.000 abstract description 13
- 102100027995 Collagenase 3 Human genes 0.000 abstract description 12
- 108050005238 Collagenase 3 Proteins 0.000 abstract description 12
- 206010051246 Photodermatosis Diseases 0.000 abstract description 12
- 230000008845 photoaging Effects 0.000 abstract description 12
- 230000002401 inhibitory effect Effects 0.000 abstract description 7
- 102000043136 MAP kinase family Human genes 0.000 abstract description 6
- 108091054455 MAP kinase family Proteins 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 5
- 230000006378 damage Effects 0.000 abstract description 3
- 230000037361 pathway Effects 0.000 abstract description 2
- 206010040844 Skin exfoliation Diseases 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 106
- 239000000843 powder Substances 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 26
- 230000000694 effects Effects 0.000 description 24
- 238000002360 preparation method Methods 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 16
- 241000699670 Mus sp. Species 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- 102000008186 Collagen Human genes 0.000 description 12
- 108010035532 Collagen Proteins 0.000 description 12
- 230000003796 beauty Effects 0.000 description 12
- 229920001436 collagen Polymers 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 235000005911 diet Nutrition 0.000 description 11
- 230000037213 diet Effects 0.000 description 11
- -1 polyoxyethylene Polymers 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 238000010171 animal model Methods 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- 229940067866 dandelion extract Drugs 0.000 description 7
- 235000020691 dandelion extract Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000037394 skin elasticity Effects 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000001845 taraxacum officinale leaf extract Substances 0.000 description 7
- 230000037373 wrinkle formation Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000009395 breeding Methods 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- 235000010356 sorbitol Nutrition 0.000 description 6
- 102000029816 Collagenase Human genes 0.000 description 5
- 108060005980 Collagenase Proteins 0.000 description 5
- 101000950695 Homo sapiens Mitogen-activated protein kinase 8 Proteins 0.000 description 5
- 102000019149 MAP kinase activity proteins Human genes 0.000 description 5
- 108040008097 MAP kinase activity proteins Proteins 0.000 description 5
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 5
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 102100037808 Mitogen-activated protein kinase 8 Human genes 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 description 5
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 108010018242 Transcription Factor AP-1 Proteins 0.000 description 4
- 102100023118 Transcription factor JunD Human genes 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229930014626 natural product Natural products 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000009822 protein phosphorylation Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 102000003945 NF-kappa B Human genes 0.000 description 2
- 108010057466 NF-kappa B Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000036570 collagen biosynthesis Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000018823 dietary intake Nutrition 0.000 description 2
- LJSQFQKUNVCTIA-UHFFFAOYSA-N diethyl sulfide Chemical compound CCSCC LJSQFQKUNVCTIA-UHFFFAOYSA-N 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940041476 lactose 100 mg Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 102000003390 tumor necrosis factor Human genes 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VFWCMGCRMGJXDK-UHFFFAOYSA-N 1-chlorobutane Chemical compound CCCCCl VFWCMGCRMGJXDK-UHFFFAOYSA-N 0.000 description 1
- SQCZQTSHSZLZIQ-UHFFFAOYSA-N 1-chloropentane Chemical compound CCCCCCl SQCZQTSHSZLZIQ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FXNDIJDIPNCZQJ-UHFFFAOYSA-N 2,4,4-trimethylpent-1-ene Chemical group CC(=C)CC(C)(C)C FXNDIJDIPNCZQJ-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 206010015548 Euthanasia Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 238000011804 SKH1 hairless mouse Methods 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000245665 Taraxacum Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229910004338 Ti-S Inorganic materials 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940037769 calcium carbonate 100 mg Drugs 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229940069647 citric acid 1000 mg Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000007783 downstream signaling Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 229940095463 folic acid 0.5 mg Drugs 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002766 immunoenhancing effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- ULYZAYCEDJDHCC-UHFFFAOYSA-N isopropyl chloride Chemical compound CC(C)Cl ULYZAYCEDJDHCC-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- SNMVRZFUUCLYTO-UHFFFAOYSA-N n-propyl chloride Chemical compound CCCCl SNMVRZFUUCLYTO-UHFFFAOYSA-N 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940078552 o-xylene Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008227 sterile water for injection Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Abstract
본 발명은 쌀겨추출물을 유효성분으로 함유하는 피부 개선용 조성물에 관한 것으로, 본 발명의 쌀겨추출물은 MAPK 경로를 억제하여 자외선 조사에 의한 MMP-13 및 COX-2 발현을 억제함으로써 자외선에 의한 피부손상에 대하여 피부보습 개선, 피부각질 제거, 피부주름 개선, 피부 광노화 개선 효과를 제공하는 건강기능식품 및 경구용 화장품 등의 소재로 유용하게 활용될 수 있다.The present invention relates to a composition for improving skin containing rice bran extract as an active ingredient, the rice bran extract of the present invention by inhibiting the MAPK pathway to inhibit the expression of MMP-13 and COX-2 by ultraviolet irradiation to damage the skin by ultraviolet rays It can be usefully used as a material for health functional foods and oral cosmetics that provides skin moisturizing, skin exfoliation, skin wrinkle improvement, and skin photoaging.
Description
본 발명은 쌀겨 추출물을 함유하는 피부 개선용 조성물 및 건강기능식품에 관한 것이다.The present invention relates to a composition for improving skin and a dietary supplement containing rice bran extract.
최근 삶의 질 향상과 건강하고 아름다운 삶에 대한 욕구가 증가함에 따라 피부미용 및 건강에 대한 관심이 확대되고 있다. 이에 건강한 피부를 유지하고자 하는 목적에 따라 다양한 미용 기능성 화장품이 개발되었으며, 특히 피부 주름형성 예방, 완화와 개선을 위한 연구가 활발히 진행되고 있다. 아울러 최근 화장품의 성분이 피부 진피에 도달하여 영양분을 공급하는데 한계가 있고, 식품으로 섭취하여 피부에 영양분 또는 기능성분을 공급하여 피부미용증진 효과를 나타낼 수 있다는 인식의 변화가 일어남에 따라 이너뷰티 식품소재들을 발굴하는 연구 또한 활발히 진행되고 있다.Recently, with the improvement of the quality of life and the desire for healthy and beautiful life, interest in skin beauty and health is expanding. Accordingly, various cosmetic functional cosmetics have been developed according to the purpose of maintaining healthy skin, and research for preventing, alleviating and improving skin wrinkle formation is being actively conducted. In addition, recently, cosmetic ingredients have a limit in supplying nutrients to the skin dermis, and as a change in the perception that the nutritional or functional ingredients can be supplied to the skin to increase skin beauty, the inner beauty food Excavations are also actively underway.
피부노화는 크게 생리학적 노화에 의한 내인성 노화, 그리고 지속적인 자외선(ultraviolet radiation, UV) 노출에 의해 일어나는 광노화로 구분된다. 반복적인 자외선 노출은 콜라겐 분해효소의 발현을 증가시키고 콜라겐 섬유의 변성 및 파괴를 유발하여 피부의 탄력을 감소시키며 주름의 생성을 촉진하는 결과를 초래한다. 즉, 지속적으로 자외선에 노출된 피부조직에는 활성 산소종(ROS)의 발생이 증가하고, growth factor receptor (EGF-R), tumor necrosis factor (TNF)-receptor 등에 의해 매개되는 신호전달체계를 통해 전염증성 사이토카인 생성을 촉진시키게 된다. 이들 수용체의 활성화는 결과적으로 MAPK(mitogenactivated protein kinase)를 포함하는 다운스트림(downstream)의 신호전달을 매개하는 단백질들을 활성화시키는 연속적인 인산화로 이루어지고, 결과적으로 activator protein-1(AP-1)과 nuclear factor κB(NF-κB)와 같은 전사인자를 활성화시켜 염증반응을 유발하고 matrix metalloproteinase(MMPs)와 같은 콜라겐 분해효소 (collagenase)의 활성을 촉진시킴으로써 피부탄력을 감소시키고 주름생성을 촉진시키게 된다. AP-1은 세포의 성장과 분화에 관련되는 수많은 유전자의 발현을 조절하고 일부 MMPs의 발현을 강력히 조절한다. AP-1에 의해 발현이 조절되는 MMP 중 MMP-13은 collagenase 13으로 알려져 있으며, type 1 내지 3의 콜라겐을 기질로 한다.Skin aging is largely divided into endogenous aging due to physiological aging and photoaging caused by continuous ultraviolet radiation (UV) exposure. Repeated UV exposure results in increased expression of collagenase and induces denaturation and destruction of collagen fibers, reducing the elasticity of the skin and promoting the production of wrinkles. That is, the generation of reactive oxygen species (ROS) increases continuously in skin tissues exposed to ultraviolet rays, and is transmitted through a signaling system mediated by growth factor receptor (EGF-R), tumor necrosis factor (TNF) -receptor, etc. Promotes inflammatory cytokine production. Activation of these receptors consists of a continuous phosphorylation that activates downstream signaling mediators, including mitogenactivated protein kinase (MAPK), resulting in activator protein-1 (AP-1) and It activates transcription factors such as nuclear factor κB (NF-κB) to induce inflammatory reactions and promotes the activity of collagenase, such as matrix metalloproteinases (MMPs), thereby reducing skin elasticity and promoting wrinkle formation. AP-1 regulates the expression of numerous genes involved in cell growth and differentiation and strongly regulates the expression of some MMPs. Among the MMPs whose expression is controlled by AP-1, MMP-13 is known as
한편, 쌀은 세계 인구의 절반이 주식으로 사용하는 세계 3대 곡물 중 하나인 귀중한 식량자원이며, 특히 아시아권에서는 다른 작물과 대치될 수 없는 국가 핵심 자원이다. 벼의 겉껍질인 왕겨를 벗기고 도정하지 않은 상태의 쌀을 현미라고 하고, 현미를 정미하여 쌀겨와 쌀눈을 벗겨낸 상태의 쌀을 백미라고 한다. 특히, 쌀겨는 정백미의 부산물임에도 불구하고 영양에 관해서는 상당히 우수한 재료이다. 쌀겨는 항암, 항산화, 항염증, 항동맥경화, 콜레스테롤 저하, 성장촉진작용, 소화기능 촉진, 면역강화 작용 등의 다양한 효능이 밝혀졌으나, 쌀겨의 섭취와 광노화 억제의 상관 관계에 대해서는 아직까지 구체적으로 밝혀진 바 없다.On the other hand, rice is a valuable food resource, one of the world's three major grains, which half of the world's population uses as a staple food, and is a key national resource that cannot be replaced by other crops, especially in Asia. Rice that has been stripped of rice husk, which is not the outer shell of rice, is called brown rice, and rice that has been polished with rice and stripped of rice bran and rice eyes is called rice. In particular, rice bran is an excellent ingredient in terms of nutrition despite being a by-product of polished rice. Rice bran has been shown to have various effects such as anti-cancer, anti-oxidation, anti-inflammatory, anti-arteriosclerosis, cholesterol lowering, growth promotion, digestive function, and immuno-enhancing effect. It has not been revealed.
본 발명자들은 부작용이 적은 천연물에서 식품으로 섭취하였을 때 주름 개선에 효과가 있는 소재를 발굴하는 연구를 진행한 결과, 쌀겨추출물이 피부보습 개선, 피부주름 개선 및 피부 광노화 개선 효과를 나타내는 것을 규명하여 본 발명을 완성하였다.The present inventors conducted a study to find a material that is effective in improving wrinkles when ingested as a food from natural products with few side effects, and found that rice bran extract exhibits improved skin moisturization, wrinkle improvement and skin photoaging effect. The invention has been completed.
본 발명은 쌀겨 추출물을 유효성분으로 포함하는 피부 개선용 식품 조성물을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a food composition for skin improvement comprising rice bran extract as an active ingredient.
본 발명의 다른 목적은 상기 피부 개선용 식품 조성물을 포함하는 건강기능성 식품을 제공하는 것이다.Another object of the present invention to provide a health functional food comprising the food composition for skin improvement.
본 발명의 또 다른 목적은 상기 피부 개선용 식품 조성물의 제조방법을 제공하는 것이다.Still another object of the present invention is to provide a method for preparing the food composition for skin improvement.
상기 목적을 달성하기 위하여, 본 발명은 쌀겨 추출물을 유효성분으로 포함하는 피부 개선용 식품 조성물을 제공한다.In order to achieve the above object, the present invention provides a food composition for skin improvement comprising the rice bran extract as an active ingredient.
또한, 본 발명은 상기 피부 개선용 식품 조성물을 포함하는 건강기능성 식품을 제공한다.In addition, the present invention provides a health functional food comprising the food composition for skin improvement.
또한, 본 발명은 쌀겨를 물, 탄소수 1 내지 4의 알코올, 또는 이들의 혼합용매로 추출하는 단계, 상기 단계에서 얻어진 쌀겨 추출물을 농축하는 단계, 상기 단계에서 얻어진 쌀겨 추출물 농축액과 폴리옥시에틸렌 소르비톨 모노라우레이트, 카제인 나트륨 및 토코페롤을 혼합하는 단계 및 상기 단계에서 얻어진 혼합물을 분무 건조하는 단계;를 포함하는 피부 개선용 식품 조성물의 제조방법을 제공한다.In addition, the present invention is the step of extracting rice bran with water, alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof, concentrating the rice bran extract obtained in the step, the rice bran extract concentrate obtained in the step and polyoxyethylene sorbitol mono It provides a method for producing a food composition for skin improvement comprising the step of mixing laurate, casein sodium and tocopherol and spray drying the mixture obtained in the step.
본 발명의 쌀겨 추출물을 유효성분으로 함유하는 식품 조성물은 피부수분 함유량 증진, 콜라겐 생합성 촉진, 콜라겐 섬유 손상 억제, 콜라겐 섬유 분해 억제, 피부 표피층의 비후 억제 활성이 우수하여 피부보습 개선, 피부탄력 증진, 피부주름 개선 및 피부 광노화 개선에 유용하게 활용될 수 있다.The food composition containing the rice bran extract of the present invention as an active ingredient has improved skin moisture content, promotes collagen biosynthesis, inhibits collagen fiber damage, inhibits collagen fiber degradation, improves skin moisturization, improves skin elasticity, and is excellent in inhibiting thickening of the skin epidermal layer. It can be usefully used to improve skin wrinkles and skin photoaging.
또한, 본 발명의 쌀겨 추출물은 천연물이므로 인체에 안전하고 부작용이 적어 건강기능식품 및 경구용 화장품 등의 소재로 다양하게 사용될 수 있다.In addition, since the rice bran extract of the present invention is a natural product, it is safe for the human body and has less side effects, and thus may be used in various materials such as health functional foods and oral cosmetics.
도 1은 실험식이를 섭취한 마우스의 체중증가량(1a) 및 피부조직의 수분함유량(1b)을 나타낸 것이다.
도 2는 실험식이를 섭취한 마우스의 피부 두께(2a) 및 피부 표피층 사진(2b)이다.
도 3은 실험식이를 섭취한 마우스의 주름 형성 정도(3a) 및 총 주름 면적(3b)을 나타낸 것이다.
도 4a 및 도 4b는 실험식이를 섭취한 동물모델에서 쌀겨추출물의 COX-2 및 MMP-13 발현 억제 효과를 나타낸 것이다.
도 5a 및 도 5b는 실험식이를 섭취한 동물모델에서 UVB-유도 MAPK 인산화에 대한 쌀겨추출물의 영향을 나타낸 웨스턴 블럿 결과를 나타낸 것이다.Figure 1 shows the weight gain (1a) and the water content (1b) of the skin tissue of the mice fed the experimental diet.
Figure 2 is a skin thickness (2a) and skin epidermal layer (2b) of the mouse fed the experimental diet.
Figure 3 shows the degree of wrinkle formation (3a) and the total wrinkle area (3b) of mice fed the experimental diet.
Figures 4a and 4b shows the effect of inhibiting the expression of COX-2 and MMP-13 of rice bran extract in the animal model of the experimental diet.
Figures 5a and 5b shows Western blot results showing the effect of rice bran extract on UVB-induced MAPK phosphorylation in animal models ingested experimental diet.
쌀겨 추출물은 항암, 항산화, 항염증, 항동맥경화, 콜레스테롤 저하, 성장촉진작용, 소화기능 촉진, 면역강화 작용을 하는 것으로 보고되고 있고, 바르는 화장료 조성물에 일부 성분으로 사용되고 있을 뿐, 쌀겨 추출물의 섭취를 통한 피부건강과 관련된 신규 활성에 대해서는 특별히 보고된 바 없다.Rice bran extract has been reported to have anti-cancer, antioxidant, anti-inflammatory, anti-arteriosclerosis, cholesterol lowering, growth-promoting, digestive function, and immune-strengthening effects. No new activity has been reported specifically for skin health.
이러한 배경 하에, 본 발명자들은 쌀겨 추출물을 동물모델에 경구 투여하여 피부건강과 관련된 쌀겨 추출물의 신규 활성을 규명하였을 뿐만 아니라, 쌀겨 추출물을 유효성분으로 함유하는 조성물을 건강기능식품, 의약, 화장품 등에 적용하기 위해 다양한 방법과 조건으로 분말을 제조하여 본 결과 산화 방지, 적절한 흐름성을 가지는 분말제조조건을 규명하여 본 발명을 완성하게 되었다.Under this background, the inventors orally administered rice bran extract to an animal model to find out the novel activity of rice bran extract related to skin health, and apply the composition containing rice bran extract as an active ingredient to health functional food, medicine, cosmetics, etc. In order to prepare the powder by various methods and conditions in order to find out the powder production conditions having oxidation prevention, proper flow to complete the present invention.
본 발명에서 제공하는 조성물은 쌀겨 추출물을 유효성분으로 포함함으로써 피부보습 개선, 피부탄력 증진, 피부주름 개선 및 피부 광노화 개선에 유용하게 활용될 수 있다.The composition provided by the present invention may be usefully used to improve skin moisturizing, skin elasticity improvement, skin wrinkles and skin photoaging by including rice bran extract as an active ingredient.
본 발명에 있어서, 상기 쌀겨 추출물은 쌀겨를 물, 유기용매 또는 이들의 혼합물을 추출 용매로 이용하여 추출한 것일 수 있다.In the present invention, the rice bran extract may be extracted by using rice bran water, an organic solvent or a mixture thereof as an extraction solvent.
예를 들어, 상기 유기용매는 저급 알코올, 헥산, 아세톤, 에틸 아세테이트, 클로로포름, 및 디에틸에테르로 이루어진 군으로부터 선택된 하나 이상의 용매일 수 있다. 상기 저급 알코올은 탄소수 1 내지 6의 알코올일 수 있다. 예를 들어, 저급 알코올로는 메탄올, 에탄올, 프로판올, 부탄올, 노말-프로판올, 이소-프로판올, 노말-부탄 올, 1-펜탄올, 2-부톡시에탄올 또는 에틸렌글리콜 등을 이용할 수 있다. 유기용매는 이 외에도 아세트산, DMFO(dimethyl-formamide), DMSO(dimethyl sulfoxide) 등의 극성 용매, 아세토나이트릴, 에틸 아세테이트, 메틸 아세테이트, 플루오로알칸, 펜탄, 2,2,4-트리메틸펜탄, 데칸, 사이클로헥산, 사이클로펜탄, 디이소부틸렌, 1-펜텐, 1-클로로부탄, 1-클로로펜탄, o-자일렌, 디이소프로필 에테르, 2-클로로프로판, 톨루엔, 1-클로로프로 판, 클로로벤젠, 벤젠, 디에틸 에테르, 디에틸 설파이드, 클로로포름, 디클로로메탄, 1,2-디클로로에탄, 어닐린, 디에틸아민, 에테르, 사염화탄소 및 THF(Tetrahydrofuran) 등의 비극성 용매를 사용할 수도 있다.For example, the organic solvent may be one or more solvents selected from the group consisting of lower alcohols, hexane, acetone, ethyl acetate, chloroform, and diethyl ether. The lower alcohol may be an alcohol having 1 to 6 carbon atoms. For example, methanol, ethanol, propanol, butanol, normal-propanol, iso-propanol, normal-butanol, 1-pentanol, 2-butoxyethanol or ethylene glycol may be used as the lower alcohol. Organic solvents include polar solvents such as acetic acid, dimethyl-formamide (DMFO) and dimethyl sulfoxide (DMSO), acetonitrile, ethyl acetate, methyl acetate, fluoroalkane, pentane, 2,2,4-trimethylpentane, and decane. , Cyclohexane, cyclopentane, diisobutylene, 1-pentene, 1-chlorobutane, 1-chloropentane, o-xylene, diisopropyl ether, 2-chloropropane, toluene, 1-chloropropane, chloro Nonpolar solvents such as benzene, benzene, diethyl ether, diethyl sulfide, chloroform, dichloromethane, 1,2-dichloroethane, anneal, diethylamine, ether, carbon tetrachloride, and THF (Tetrahydrofuran) can also be used.
본 발명의 일 구현예에 의하면, 상기 쌀겨 추출물은 쌀겨의 저급 알코올 추출물일 수 있으며, 바람직하게는 쌀겨의 에탄올 추출물일 수 있다.According to one embodiment of the invention, the rice bran extract may be a lower alcohol extract of rice bran, preferably may be an ethanol extract of rice bran.
한편, 본 명세서에서 용어 유효성분으로 포함하는이란 쌀겨 추출물의 효능 또는 활성을 달성하는 데 충분한 양을 포함하는 것을 의미한다. 본 발명의 한 구체예에서, 본 발명의 조성물 내에서 쌀겨 추출물 또는 쌀겨 분말은 예를 들어, 1.0 mg/kg 이상, 바람직하게는 100 mg/kg 이상, 보다 바람직하게는 500 mg/kg 이상, 이상 포함된다.On the other hand, the term included herein as an active ingredient means to include an amount sufficient to achieve the efficacy or activity of the rice bran extract. In one embodiment of the present invention, the rice bran extract or rice bran powder in the composition of the present invention is, for example, at least 1.0 mg / kg, preferably at least 100 mg / kg, more preferably at least 500 mg / kg, at least Included.
쌀겨 추출물은 천연물로서 과량 투여하여도 인체에 부작용이 없으므로 본 발명의 조성물 내에 포함되는 쌀겨 추출물 또는 쌀겨 분말의 양적 상한은 당업자가 적절한 범위 내에서 선택 하여 실시할 수 있다.Since the rice bran extract is a natural product, even if it is excessively administered, there is no side effect to the human body, so that the upper limit of the amount of the rice bran extract or rice bran powder included in the composition of the present invention can be carried out by those skilled in the art.
본 명세서에서 쌀겨를 언급하면서 사용되는 용어 추출물은 쌀겨에 추출용매를 처리하여 얻은 조추출물뿐 만 아니라 쌀겨 추출물의 가공물도 포함한다. 예를 들어, 쌀겨 추출물은 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조될 수 있다.The term extract used while referring to rice bran herein includes not only the crude extract obtained by treating the extraction solvent on the rice bran, but also the processed product of the rice bran extract. For example, rice bran extract may be prepared in powder form by additional processes such as distillation under reduced pressure and freeze drying or spray drying.
본 발명의 바람직한 구현예에 따르면, 본 발명의 피부 개선용 식품 조성물에 있어서, 상기 쌀겨 추출물은 쌀겨를 용매로 추출하여 농축한 후 분무건조 하여 제조하는 것이 쌀겨 추출물을 건강기능성 식품에 적용함에 있어서 산패 억제 및 가공성을 높이는 측면에서 바람직하다.According to a preferred embodiment of the present invention, in the food composition for skin improvement of the present invention, the rice bran extract is prepared by extracting the rice bran with a solvent and then concentrated by spray drying in the application of rice bran extract to health functional food It is preferable at the point of improving suppression and workability.
또한, 본 발명의 바람직한 구현예에 따르면, 본 발명의 피부 개선용 식품 조성물에 있어서, 상기 쌀겨 추출물은 폴리옥시에틸렌 소르비톨 모노라우레이트, 카제인 나트륨 및 토코페롤을 전부 또는 일부로 혼합하여 제조한 쌀겨 추출물 분말인 것이 산패 억제 및 가공성을 높이는 측면에서 바람직하다.In addition, according to a preferred embodiment of the present invention, in the food composition for skin improvement of the present invention, the rice bran extract is a rice bran extract powder prepared by mixing all or part of polyoxyethylene sorbitol monolaurate, casein sodium and tocopherol It is preferable from the viewpoint of suppressing rancidity and improving workability.
본 발명의 바람직한 구현예에 따르면, 본 발명의 상기 피부 개선용 식품 조성물은 경구용 화장료 조성물인 것을 특징으로 한다.According to a preferred embodiment of the present invention, the skin improvement food composition of the present invention is characterized in that the oral cosmetic composition.
본 발명의 피부 개선용 식품 조성물에 있어서, 상기 피부 개선은 피부 보습, 피부 주름 개선, 피부 광손상 개선 또는 피부 홍반 감소를 통해 이루어지는 것을 특징으로 한다.In the food composition for skin improvement of the present invention, the skin improvement is characterized by consisting of skin moisturizing, skin wrinkle improvement, skin photodamage improvement or skin erythema reduction.
본 발명에서 용어 "피부주름 개선"은 피부의 주름 및 탄력과 관련된 능력을 유지 또는 강화시키는 것을 의미 한다. 피부 진피층의 교원섬유인 콜라겐(collagen)과 탄력섬유인 엘라스틴(elastin)이 그러한 역할을 하는 주요 단백질로서 피부 탄력을 주관하는데, 콜라겐의 생합성은 피부의 내, 외적 영향을 받게 된다. 구체적으로, 피부 세포는 자연 노화로 인하여 세포 활성이 감소되면 콜라겐 섬유의 감소가 일어나거나, 또는 외적요인으로서 자외선의 과량 조사되거나 스트레스 등에 의해 생성된 활성 산소가 단백질의 티올기(thiol: -SH)와 반응하여 효소 활성을 저해하거나, 콜라겐, 엘라스틴 등의 분해 효소의 발현을 증가시켜 피부의 주름을 증가시키고 탄력을 감소시켜 피부 노화가 진행된다.As used herein, the term "improvement of skin wrinkles" means maintaining or enhancing the ability to be associated with wrinkles and elasticity of the skin. Collagen (collagen) and elastic fiber elastin (collagen) in the dermal layer of the skin is the main protein that plays a role in the skin elasticity, collagen biosynthesis is affected by the internal and external skin. Specifically, when skin cells are reduced in cell activity due to natural aging, a decrease in collagen fibers occurs, or free radicals generated by excessive irradiation of UV rays or stress as external factors cause the protein's thiol group (thi-SH). In response to inhibiting the enzyme activity or by increasing the expression of degradation enzymes, such as collagen, elastin, increase the wrinkles of the skin and decrease the elasticity to progress the skin aging.
본 발명의 일 실시예에서는 자외선 조사와 함께 쌀겨 추출물을 함유하는 실험 식이를 무모생쥐에게 16주간 공급하여, 실험동물의 피부수분 함유량, 등피부조직의 주름, 피부두께 변화, 피부조직의 MMP-13 유전자 발현 등을 측정하였다. 그 결과, 쌀겨 추출물은 피부 수분함유량을 증가시키고(도 1b), 자외선 조사에 의해 비후해진 표피층의 두께 또한 현저하게 감소시킴을 확인하였다(도 2a 및 2b). 또한, 쌀겨 추출물은 실험동물의 등 피부조직 주름을 개선시키고, 피부주름 면적, 깊이 및 길이를 유의하게 감소시켜 주름생성을 현저하게 억제하는 효과가 있으며(도 3a 및 3b), COX-2 및 MMP-13 유전자 발현을 유의하게 감소시킴으로써 콜라겐 단백질의 합성을 증가시키고 콜라겐 섬유의 분해를 저해하여 자외선 조사에 의한 주름형성을 효과적으로 억제함을 확인하였다(도 4a 및 4b).In one embodiment of the present invention by feeding the experimental diet containing rice bran extract to the hairless mice with UV irradiation for 16 weeks, the skin moisture content of the experimental animal, wrinkles of the back skin tissue, changes in skin thickness, skin tissue MMP-13 Gene expression and the like were measured. As a result, it was confirmed that rice bran extract increased the skin moisture content (Fig. 1b), and also significantly reduced the thickness of the epidermal layer thickened by ultraviolet irradiation (Fig. 2a and 2b). In addition, the rice bran extract has the effect of improving the wrinkles of the back skin tissue of the experimental animal, significantly reducing the wrinkle area, depth and length to significantly reduce the formation of wrinkles (Figs. 3a and 3b), COX-2 and MMP Significantly reduced -13 gene expression increased collagen protein synthesis and inhibited the degradation of collagen fibers to effectively inhibit wrinkle formation by ultraviolet irradiation (Figs. 4a and 4b).
따라서, 본 발명의 쌀겨 추출물을 함유하는 조성물은 피부보습 개선, 피부주름 개선, 피부 광노화 개선 효과를 제공하는 건강기능식품 및 경구용 화장품 등의 소재로 유용하게 활용될 수 있다.Therefore, the composition containing the rice bran extract of the present invention can be usefully used as a material for health functional foods and oral cosmetics, such as to improve the skin moisturizing, improve wrinkles, improve skin photoaging.
이에 본 발명은 피부 개선용 식품 조성물을 포함하는 건강기능성 식품에 관한 것이다.Accordingly, the present invention relates to a health functional food comprising a food composition for skin improvement.
본 발명에서 용어 "건강기능식품"은 인체에 유용한 기능성을 가진 원료나 성분을 사용하여 정제, 캅셀, 분말, 과립, 액상 및 환 등의 형태로 제조 및 가공한 식품을 말한다. 여기서 '기능성'이라 함은 인체의 구조 및 기능에 대하여 영양소를 조절하거나 생리학적 작용 등과 같은 보건용도에 유용한 효과를 얻는 것을 의미한다. 본 발명의 건강기능식품은 당 업계에서 통상적으로 사용되는 방법에 의하여 제조가능하며, 상기 제조 시에는 당 업계 에서 통상적으로 첨가하는 원료 및 성분을 첨가하여 제조할 수 있다. 또한 상기 건강기능식품의 제형 또한 건강 기능식품으로 인정되는 제형이면 제한 없이 제조될 수 있다. 본 발명의 건강기능식품 조성물은 일반 약품과는 달리 식품을 원료로 하여 약품의 장기 복용 시 발생할 수 있는 부작용 등이 없는 장점이 있고, 휴대성이 뛰어나, 피부보습 개선, 피부탄력 증진, 피부주름 개선 및/또는 피부 광노화 개선 효과를 증진시키기 위한 보조제로 섭취가 가능하다.In the present invention, the term "health functional food" refers to a food prepared and processed in the form of tablets, capsules, powders, granules, liquids and pills using raw materials or ingredients having useful functions for the human body. Here, 'functional' means to obtain a useful effect for health purposes such as nutrient control or physiological action on the structure and function of the human body. The health functional food of the present invention can be prepared by a method commonly used in the art, and the preparation can be prepared by adding raw materials and ingredients commonly added in the art. In addition, the formulation of the health functional food can also be prepared without limitation as long as the formulation is recognized as a health functional food. Unlike the general medicine, the health functional food composition of the present invention has the advantage that there are no side effects that may occur when taking a long-term use of the drug as a raw material, and has excellent portability, improving skin moisturizing, enhancing skin elasticity, and improving skin wrinkles. And / or as an adjuvant to enhance skin photoaging improvement.
본 발명의 피부 개선용 식품 조성물은 정제, 과립, 분말, 캅셀, 액상의 용액 및 환으로 이루어진 군으로부터 선택된 어느 하나의 제형으로 제조된 것일 수 있다.The food composition for skin improvement of the present invention may be prepared in any one formulation selected from the group consisting of tablets, granules, powders, capsules, liquid solutions and rings.
본 발명의 바람직한 구현예에 따르면, 본 발명의 피부 개선용 식품 조성물은 쌀겨 추출물을 유효성분으로 포함시켜 분말제, 액제, 정제, 연질 캅셀제, 과립제, 티백차, 인스턴트 차 또는 드링크제 등의 형태로 제형화될 수 있다. 유효성분으로서의 쌀겨추출물의 함량은 그 사용 목적(예방 또는 개선용)에 따라 적합하게 결정될 수 있다. 일반적으로, 건강기능식품 조성물 중에 포함되는 쌀겨추출물의 양은 전체 식품 중량의 0.1 내지 90 중량%로 가할 수 있다. 그러나 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있다. 또한, 본 발명에 따른 건강기능식품 조성물은 쌀겨추출물 이외에 본 발명이 목적으로 하는 주효과를 손상시키지 않는 범위 내에서 바람직하게는 주효과에 상승효과를 줄 수 있는 다른 성분 예를 들면, 비타민 C와 같은 주름 개선용 화합물 또는 녹차 추출물, 어성초 추출물, 감초추출물, 상백피 추출물, 홍경천 추출물, 황금 추출물, 산삼 추출물 등의 천연물을 함유하는 것도 무방하다.According to a preferred embodiment of the present invention, the food composition for skin improvement of the present invention comprises rice bran extract as an active ingredient in the form of powder, liquid, tablets, soft capsules, granules, tea bags, instant tea or drink Can be converted. The content of rice bran extract as an active ingredient can be suitably determined according to the purpose of use (prevention or improvement). In general, the amount of rice bran extract contained in the nutraceutical composition may be added to 0.1 to 90% by weight of the total food weight. However, in the case of prolonged intake for health and hygiene purposes or health control purposes, the amount may be below the above range. In addition, the health functional food composition according to the present invention, in addition to the rice bran extract within the range that does not impair the main effect for the purpose of the present invention, for example, vitamin C and other ingredients that can have a synergistic effect on the main effect It may also contain natural compounds such as compounds for improving wrinkles or green tea extracts, eoseongcho extract, licorice extract, lettuce extract, honggyeongcheon extract, golden extract, wild ginseng extract.
상기와 같은 형태로 제형화된 건강기능식품 조성물은 식품에 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 식품의 예로는 드링크제, 육류, 소시지, 빵, 비스킷, 떡, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농 제품, 각종 스프, 음료수, 알코올 음료 및 비타민 복합제, 유제품 및 유가공 제품 등이 있으며, 통상적인 의미에서의 건강기능식품은 모두 포함한다.The dietary supplement composition formulated in the form as described above may be added to the food as it is or used with other foods or food ingredients, and may be appropriately used according to conventional methods. Examples of foods include drinks, meat, sausages, breads, biscuits, rice cakes, chocolates, candy, snacks, confectionery, pizza, ramen, dairy products including other noodles, gums, ice creams, various soups, beverages, alcoholic beverages and vitamin complexes. , Dairy products and dairy products, and all functional foods in the conventional sense.
본 발명의 건강기능식품 조성물이 드링크제인 경우는 지시된 비율로 필수성분으로서 쌀겨추출물을 함유하며, 그밖의 드링크제 제조를 목적으로 사용되는 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제 및 합성 향미제 등을 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 1 내지 20g, 바람직하게는 약 5 내지 12 g이다.When the health functional food composition of the present invention is a drink, it contains rice bran extract as an essential ingredient at the indicated ratio, and there are no special restrictions on other ingredients used for the manufacture of other drinks, and various flavoring agents such as ordinary drinks. Or natural carbohydrate or the like as an additional component. Examples of such natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As a flavoring agent other than the above-mentioned, a natural flavoring agent, a synthetic flavoring agent, etc. can be used. The proportion of said natural carbohydrates is generally about 1-20 g, preferably about 5-12 g per 100 ml of the composition of the present invention.
또한 본 발명의 건강기능식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할수 있다. 그 밖에도 본 발명의 본 발명의 식품 조성물은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 쌀겨추출물 100 중량부 당 0.1 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.In addition, the nutraceutical composition of the present invention is a variety of nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese, chocolate), pectic acid and salts thereof, alginic acid And salts thereof, organic acids, protective colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, and the like. In addition, the food composition of the present invention may contain a pulp for producing natural fruit juice and fruit juice beverage and vegetable beverage. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected in the range of 0.1 to about 20 parts by weight per 100 parts by weight of the rice bran extract of the present invention.
본 발명의 바람직한 구현예에 따르면, 본 발명의 건강기능성 식품은 이너뷰티 푸드(inner beauty) 형태로 섭취함으로써 더욱 우수한 피부보습 개선효과를 갖는 장점을 가진다. 상기 이너뷰티(inner beauty)는먹는 화장품 또는 뷰티푸드로 일컬어지는 이너뷰티 푸드로, 피부에 좋은 여러 가지 성분을 몸속으로 흡수시켜 피부 체질을 건강하게 바꾸는 식품을 지칭하며, 피부 타입에 맞는 화장품을 고르듯 피부 컨디션과 라이프 스타일을 고려해 개개인에게 맞는 이너뷰티 푸드를 선택하여 섭취할 수 있다. 보다 바람직하게는 상기 화장료 조성물을 포함하는 화장품과 상기 화합물을 포함하는 이너뷰티 푸드를 혼용할 경우, 화장품만 사용하는 것에 비해 피부미백 개선효과가 월등히 높아져 더욱 효과적인 피부보습 개선 효과를 볼 수 있는 장점을 가진다.According to a preferred embodiment of the present invention, the health functional food of the present invention has the advantage of having an improved skin moisturizing effect by ingesting in the form of inner beauty (inner beauty) food. The inner beauty (inner beauty) is an inner beauty food, called cosmetics or beauty foods to eat, refers to a food that changes the physical constitution of the skin by absorbing a variety of ingredients that are good for the skin, and choose a cosmetic that fits the skin type Considering your skin condition and lifestyle, you can choose the inner beauty food that suits you. More preferably, when the cosmetic composition containing the cosmetic composition and the inner beauty food containing the compound are mixed, the skin whitening improvement effect is significantly higher than that of using only the cosmetics, so that the effect of improving the skin's moisturizing effect is improved. Have
본 발명은 또한, 쌀겨추출물을 유효성분으로 함유하는 피부보습 개선, 피부탄력 증진, 피부주름 개선 및/또는 피부 광노화 개선 효과를 갖는 의약외품 또는 의약 조성물에 관한 것이다.The present invention also relates to quasi-drugs or pharmaceutical compositions having the effect of improving skin moisturizing, enhancing skin elasticity, improving skin wrinkles and / or improving skin photoaging, containing rice bran extract as an active ingredient.
본 발명의 쌀겨추출물을 의약품으로 사용하는 경우, 추가로 동일 또는 유사한 기능을 나타내는 유효성분을 1종 이상 함유할 수 있다. 예컨대, 공지의 피부 주름 개선 성분 또는 탄력 증진 성분을 포함할 수 있을 것이다. 추가적인 피부 주름 개선 성분 및 탄력 증진 성분을 포함하게 되면 본 발명의 조성물의 주름개선 및 탄력 증진 효과는 더욱 증진될 수 있다. 상기 성분 추가 시에는 복합 사용에 따른 피부 안전성, 제형화의 용이성, 유효성분들의 안정성을 고려할 수 있다. 본 발명의 일실시예에서, 상기 의약품 조성 물은 당업계에 공지된 주름 개선 성분으로서, 비타민 C, 레티노산, TGF, 동물 태반 유래의 단백질, 베툴린산 및 클로렐라 추출물로 이루어진 군으로부터 선택되는 어느 하나 이상의 피부 주름 개선 성분을 추가로 포함할 수있다. 추가의 피부주름 개선 성분은 전체 조성물 중량에 대하여 0.0001 내지 10 중량%로 포함될 수 있을 것이며, 상기 함량 범위는 콜라겐 합성 촉진 활성, 피부 안전성, 쌀겨추출물의 제형화 시의 용이성 등의 요건에 따라 조절될 수 있을 것이다.When using the rice bran extract of the present invention as a medicine, it may further contain one or more active ingredients exhibiting the same or similar function. For example, it may include known skin wrinkle improving ingredients or elasticity enhancing ingredients. By including additional skin wrinkle improving component and elasticity enhancing component, the wrinkle improvement and elasticity enhancing effect of the composition of the present invention can be further enhanced. When the ingredient is added, skin safety, ease of formulation, and stability of the active ingredients may be considered. In one embodiment of the present invention, the pharmaceutical composition is a wrinkle improving component known in the art, any one selected from the group consisting of vitamin C, retinoic acid, TGF, protein from animal placenta, betulinic acid and chlorella extract The skin may further contain wrinkle improvement ingredients. Additional skin wrinkle improving ingredients may be included in 0.0001 to 10% by weight based on the total weight of the composition, the content range may be adjusted according to requirements such as collagen synthesis promoting activity, skin safety, ease of formulating rice bran extract, etc. Could be.
또한, 본 발명의 피부 보습용 약학적 조성물은 약학적으로 허용 가능한 담체를 더 포함할 수 있다. 약학적으로 허용되는 담체는 완충액, 주사용 멸균수, 일반 식염수 또는 인산염 완충 식염수, 수크로오스, 히스티딘, 염 및 폴리솔베이트 등과 같은 여러 성분을 함유할 수 있다.In addition, the pharmaceutical composition for moisturizing the skin of the present invention may further comprise a pharmaceutically acceptable carrier. Pharmaceutically acceptable carriers may contain various components such as buffers, sterile water for injection, general saline or phosphate buffered saline, sucrose, histidine, salts, polysorbates and the like.
본 발명의 약학적 조성물은 경구 또는 비경구로 투여할 수 있으며, 일반 의약품 제제의 형태, 예를 들어, 임상 투여 시 경구 및 비경구의 여러 가지 제형으로 투여될 수 있는데, 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제될 수 있다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 본 발명의 약학적 조성물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘 카보네이트(Calcium carbonate), 수크로오스 (Sucrose) 또는 락토오스(Lactose), 젤라틴 등을 섞어 조제될 수 있다.단순한 부형제 이외에 마그네슘 스티레이트 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제, 좌제가 포함된다. 비수 성용제, 현탁용제로는 프로필렌 글리콜(Propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크 로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.The pharmaceutical composition of the present invention may be administered orally or parenterally, and may be administered in the form of a general pharmaceutical preparation, for example, in various dosage forms, orally and parenterally, during clinical administration. , Diluents or excipients such as extenders, binders, wetting agents, disintegrants, surfactants and the like. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and such solid preparations include at least one excipient in the pharmaceutical composition of the present invention, for example, starch, calcium carbonate, Sucrose, lactose, gelatin, etc. may be mixed. In addition to simple excipients, lubricants such as magnesium styrate talc are also used. Oral liquid preparations include suspensions, solvents, emulsions, and syrups, and may include various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents such as water and liquid paraffin. . Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, lyophilized preparations, suppositories. As the non-aqueous solvent and the suspension solvent, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like can be used. As the base of the suppository, witepsol, macrologol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.
본 발명의 의약품 조성물은 유효량의 쌀겨추출물을 포함할 때 바람직한 피부보습 개선, 피부탄력 증진, 피부주름 개선 또는 피부광노화 개선 효과를 제공할수 있다. 본 발명에 있어서, '유효량'이라 함은 피부의 주름이 생성되는 것을 억제 또는 저해하거나, 이미 생성된 주름을 완화시킬 수 있는 화합물의 양을 의미한다. 본 발명의 조성물에 포함되는 쌀겨추출물의 유효량은 조성물이 제품화되는 형태, 상기 화합물이 피부에 적용되는 방법 및 피부에 머무르는 시간 등에 따라 달라질 것이다. 예컨대, 상기 조성물이 피부의 주름 생성, 탄력 감소, 기미 등에 따른 피부과적 치료를 위한 의약품으로 제품화되는 경우에는 일상적으로 피부에 적용하게 되는 화장품으로 제품화되는 경우에 비해 높은 농도로 쌀겨추출물을 포함할 수 있을 것이다.The pharmaceutical composition of the present invention may provide a desirable skin moisturizing improvement, skin elasticity improvement, skin wrinkle improvement or skin photoaging improvement effect when an effective amount of rice bran extract is included. In the present invention, the term 'effective amount' means an amount of a compound capable of inhibiting or inhibiting generation of wrinkles on the skin or alleviating wrinkles already produced. The effective amount of rice bran extract included in the composition of the present invention will vary depending on the form in which the composition is commercialized, the method in which the compound is applied to the skin, the time it stays on the skin, and the like. For example, when the composition is commercialized as a medicament for dermatological treatment due to wrinkle formation, elasticity reduction, and blemishes of the skin, rice bran extract may be contained at a higher concentration than when it is commercialized as a cosmetic product that is routinely applied to the skin. There will be.
본 발명은 또한, 상기 쌀겨추출물을 건강기능성 식품 및 경구용 화장품에 적용하기 위하여 산패를 억제하여 쌀겨의 유효성분을 효과적으로 보호하고, 분말의 흐름성(유동성)을 향상시켜 가공성이 뛰어난 쌀겨 추출물 분말을 포함하는 피부 개선용 식품 조성물을 제조하는 방법에 관한 것이다.The present invention also suppresses rancidity in order to apply the rice bran extract to health functional foods and oral cosmetics to effectively protect the active ingredient of rice bran, improve the flowability (flow) of the powder to improve rice bran extract powder It relates to a method for producing a food composition for skin improvement comprising.
본 발명의 바람직한 구현예에 의하면, 본 발명의 제조방법은, 쌀겨를 물, 탄소수 1 내지 4의 알코올, 또는 이들의 혼합용매로 추출하는 단계; 상기 단계에서 얻어진 쌀겨 추출물을 농축하는 단계; 상기 단계에서 얻어진 쌀겨 추출물 농축액과 폴리옥시에틸렌 소르비톨 모노라우레이트, 카제인나트륨 및 토코페롤을 혼합하는 단계; 및 상기 단계에서 얻어진 혼합물을 분무 건조하는 단계를 포함한다.According to a preferred embodiment of the present invention, the manufacturing method of the present invention, the step of extracting rice bran with water, alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof; Concentrating the rice bran extract obtained in the step; Mixing the rice bran extract concentrate obtained in the step with polyoxyethylene sorbitol monolaurate, sodium casein and tocopherol; And spray drying the mixture obtained in the step.
본 발명의 바람직한 구현예에 의하면, 본 발명의 제조방법에 있어서, 상기 쌀겨를 추출하는 단계에서 사용되는 쌀겨는 도정 후 3일 이내의 원료를 사용하여 추출함으로써 산패가 되지 않는 제품을 제조할 수 있다. 하기 표 1은 저장일수에 따른 쌀겨 원료의 산가 변화를 나타낸 것이다.According to a preferred embodiment of the present invention, in the manufacturing method of the present invention, the rice bran used in the step of extracting the rice bran can be produced a product that does not become rancid by extracting using raw materials within 3 days after milling. . Table 1 shows the acid value change of the rice bran raw material according to the storage days.
본 발명의 바람직한 구현예에 의하면, 본 발명의 제조방법에 있어서, 상기 혼합하는 단계는 쌀겨 분말의 흐름성을 향상시키고 산패를 방지하기 위하여 쌀겨 추출물의 농축액에 폴리옥시에틸렌 소르비톨 모노라우레이트, 카제인나트륨 및 토코페롤(천연항산화제)을 투입하고 혼합하는 것이 바람직하다.According to a preferred embodiment of the present invention, in the manufacturing method of the present invention, the mixing step is polyoxyethylene sorbitol monolaurate, casein sodium in the concentrate of rice bran extract to improve the flowability of rice bran powder and prevent rancidity And tocopherol (natural antioxidant) is preferably added and mixed.
본 발명의 바람직한 구현예에 의하면, 본 발명의 제조방법에 있어서 상기 혼합하는 단계는 쌀겨 추출물 농축액 100중량부에 대하여 폴리옥시에틸렌 소르비톨 모노라우레이트 0.5 내지 1.5 중량부, 카제인 나트륨 2 내지 5 중량부 및 토코페롤 0.005 내지 0.1 중량부를 첨가하여 혼합하는 것이 바람직하다. 상술한 함량 범위를 벗어나는 경우에는 분말의 흐름성이 급격히 저하될 수 있다.According to a preferred embodiment of the present invention, the mixing step of the manufacturing method of the present invention is 0.5 to 1.5 parts by weight of polyoxyethylene sorbitol monolaurate, 2 to 5 parts by weight of sodium casein and 100 parts by weight of rice bran extract concentrate and It is preferable to add 0.005 to 0.1 parts by weight of tocopherol and mix. If it is out of the above-described content range, the flowability of the powder may be sharply lowered.
본 발명의 상기 제조방법에 의해 제조된 쌀겨 추출물 분말을 포함하는 피부 개선용 식품 조성물은 산패가 방지되어 유효성분의 함량이 장기간 높게 유지되고 분말의 흐름성이 우수하여 건강기능식품 및 경구 화장품 제조 등에 다양하게 활용될 수 있다.Skin improvement food composition comprising the rice bran extract powder prepared by the production method of the present invention is to prevent rancidity, the content of the active ingredient is maintained for a long time and the flow of the powder is excellent, for the production of health functional foods and oral cosmetics, etc. It can be used in various ways.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as limited by these examples.
실시예 1. 쌀겨추출물의 제조Example 1 Preparation of Rice Bran Extract
도정과정 중에 쌀에서 쌀겨 층을 벗기면 리파아제(lipase)의 작용으로 쌀겨의 산패가 급속도로 일어나게 된다. 도정 이후 5일이 경과하면 산패도가 급격하게 증가하는 것으로 나타났다. 이에 사용원료인 쌀겨를 도정 후 3일 이내의 쌀겨로부터 추출 온도는 30~50℃, 추출 시간은 2~16 시간으로 하여 쌀겨 에탄올 추출물을 제조하여 본 결과 40±3℃의 온도에서 8시간 동안 추출한 쌀겨 추출물이 유효성분의 함량이 높아 피부보습 효과가 우수함을 확인하여 상기 조건으로 쌀겨 에탄올 추출물을 제조하였다. 하기 표 2는 쌀겨 에탄올 추출물의 추출 조건별 수율 및 유효성분의 함량을 나타낸 것이다.Peeling the rice bran layer from the rice during the milling process causes the rancidity of the rice bran to rise rapidly due to the action of lipase. After 5 days, the degree of rancidity increased rapidly. Thus, rice bran ethanol extract was prepared from the rice bran within 3 days after the induction of rice bran as the raw material, and the extraction time was 2 to 16 hours, and extracted for 8 hours at the temperature of 40 ± 3 ° C. Rice bran extract has a high content of the active ingredient confirmed that the skin moisturizing effect is excellent to prepare a rice bran ethanol extract under the above conditions. Table 2 shows the yield and the amount of the active ingredient according to the extraction conditions of the rice bran ethanol extract.
실시예 2. 쌀겨 추출물 분말의 제조Example 2. Preparation of Rice Bran Extract Powder
이너뷰티 제품으로 활용성을 높이기 위해서는 환, 캡슐, 타정 제형으로의 제조가 요구된다. 이에 상기 제형을 제조하기에 적합한 흐름성을 가지는 쌀겨추출물 분말을 제조하였다. 실시예 1에서 제조된 쌀겨추출물을 여과한 후 진공감압농축기를 사용하여 65℃ 이하의 온도에서 13±2 Brix가 되도록 농축시켰다. 농축된 쌀겨 추출물 농축액 100 중량부에 대하여 하기 표 3과 같이 첨가제를 각각 투입하고 3000 rpm으로 10분 동안 교반하여 균질화한 후, 80±3℃의 온도에서 15분 동안 살균시키고 분무건조 방식을 이용하여 입구온도는 160℃, 출구온도는 90℃ 및 유속은 8-10 L/h의 조건하에 건조시켜 쌀겨 추출물 분말을 제조하였다.In order to increase its utility as an inner beauty product, it needs to be prepared into a pill, capsule, or tablet formulation. Thus, rice bran extract powder having a flowability suitable for preparing the formulation was prepared. The rice bran extract prepared in Example 1 was filtered and concentrated using a vacuum pressure reducer to a temperature of 13 ± 2 Brix at a temperature of 65 ° C. or lower. 100 parts by weight of the concentrated rice bran extract concentrate was added to each of the additives as shown in Table 3 below, homogenized by stirring at 3000 rpm for 10 minutes, sterilized at a temperature of 80 ± 3 ° C. for 15 minutes, and using a spray drying method. The rice bran extract powder was prepared by drying under the conditions of an inlet temperature of 160 ° C., an outlet temperature of 90 ° C., and a flow rate of 8-10 L / h.
실험예 1. 쌀겨 추출물 분말의 흐름성 확인Experimental Example 1. Check the flowability of the rice bran extract powder
실시예 2 및 비교예 1 내지 8의 쌀겨 추출물 분말에 대한 분말의 흐름성을 알아보기 위하여, 각 시료를 30g 씩 채취하여 100 rpm으로 2분 동안 교반한 후 응집도와 유동성을 측정하였다. 응집도는 육안으로 확인하여 분말 입자의 응집현상이 전혀 없었음(×), 응집현상이 다소 있음(△), 응집현상이 보통임(○), 응집현상이 많음(◎)을 기준으로 평가하였다. 또한, 유동성(㎤/sec)은 내부직경 3.5㎝ 및 길이 60㎝ 유리관의 상단과 하단 사이에 체적 288㎤이 되는 곳의 표지 사이(30㎝)에 분말이 통과하는 시간을 측정하여 단위시간당 통과하는 체적을 구하여 분말의 유동성을 평가하였으며, 그 결과는 하기 표 4에 나타내었다.In order to determine the flowability of the powder to the rice bran extract powder of Example 2 and Comparative Examples 1 to 8, each sample was taken 30g and stirred at 100 rpm for 2 minutes to measure the cohesiveness and fluidity. The degree of cohesion was visually determined and evaluated based on the fact that there was no agglomeration of the powder particles (×), a slight agglomeration phenomenon (△), a moderate agglomeration phenomenon (○), and a high agglomeration phenomenon (◎). In addition, the fluidity (
실험예 2. 쌀겨추출물 분말의 산패도 변화Experimental Example 2. Changes in Acidity of Rice Bran Extract Powder
실시예 2 및 비교예 1 내지 8의 쌀겨 추출물 분말에 대한 저장 중 산가변화를 알아보기 위하여, 쌀겨의 산가를 측정하기 위해 쌀겨 100g을 측량하여 용기에 담아 추출용매(n-hexane) 300ml을 넣어 1시간 동안 상온에서 2~3회 흔들어 주며 유지를 추출 하였으며, 이와 동일한 방법으로 2회 추출 하였고, 추출이 종료되면 건조여과지에 무수황산을 넣어 여과하고 여과액을 완전 감압 농축하여 유지를 얻었다. 유지 시료를 약 1~3g을 취하여 공전 삼각플라스크에 넣고 에탄올-에테르(1:2) 혼합액 10㎖를 가하여 용해시킨 다음, Phenolphthalein을 지시약으로 하여 엷은 홍색이 30초간 지속될 때까지 0.1N 알코올성 KOH 용액으로 적정하였으며, 그 결과는 하기 표 5과 같다. In order to determine the acid value change during storage for the rice bran extract powder of Example 2 and Comparative Examples 1 to 8, in order to measure the acid value of the rice bran 100g of rice bran and put in a container 300ml of extraction solvent (n-hexane) 1 The oil was extracted by shaking 2-3 times at room temperature for 2 hours, and extracted twice by the same method. When extraction was completed, sulfuric anhydride was added to the dried filter paper and the filtrate was concentrated under reduced pressure to obtain a fat or oil. Take about 1 to 3 g of the oil and fat solution, put it in an erlenmeyer flask, and dissolve 10 ml of ethanol-ether (1: 2) mixture. Titration, and the results are shown in Table 5.
실시예 3. 시험물질, 실험동물의 사육 및 자외선 조사Example 3. Breeding of test material, laboratory animals and UV irradiation
시험물질인 쌀겨추출물은 실시예 1 내지 2의 방법으로 제조하여 준비하였으며, 양성대조군으로 식품의약품안전처로부터 "피부보습" 기능성으로 생리활성 2등급을 받은 민들레추출물을 선택하였다. 민들레추출물은 민들레 분말(100% 국산, 맑은들(주), 강원도 홍천) 18g에 80% 에탄올을 첨가하여 24시간 동안 정치추출 하였다. 추출물은 회전식증발농축기(SB-1200, EYELA, Tokyo, Japan)를 이용하여 농축하였고, 동결건조를 통해 분말화하였다.Rice bran extract, a test substance, was prepared and prepared by the method of Examples 1 to 2, and the dandelion extract, which received
본 실시예에 사용한 6주령의 암컷 무모 생쥐(SKH-1 hairless mouse)는 중앙실험동물(주) (Seoul, Korea)에서 구입하여 1주일간 적응시킨 후 사용하였다. 실험동물은 5개 군으로 분류하고 군별로 10 마리씩 배정하여 실험에 사용하였다. 실험군은 자외선을 조사하지 않은 정상 대조군(normal), 자외선 조사군(UV), 자외선조사와 함께 쌀겨추출물(0.1% diet or 0.5% diet) 또는 민들레추출물을 섭취시킨 군으로 나누었다. 사육기간 동안 사료와 물을 자유로이 섭취하도록 하였으며, 온도는 23±2℃, 습도는 40~60%로 유지하고 매일 광주기와 암주기가 12시간이 되도록 조절하였다. 쌀겨추출물 섭취군은 제조예의 방법으로 제조한 쌀겨추출물을 0.1% 또는 0.5% 첨가하여 제조된 식이를 16주간 공급하였고, 민들레 추출물 섭취군은 상기 방법으로 제조한 민들레 추출물을 0.5% 첨가한 식이로 16주간 사육하였다. 식이는 매일 오후 2시에 물과 함께 공급하였으며, 식이 섭취량은 매일 측정하였다. 실험사육기간 동안 무모 생쥐의 등 부분에 ultraviolet B(UVB)를 주 3회 조사하였으며 자외선 조사량은 처음 1주 동안은 1 MED(1 MED = 0.5 J/㎠, MED; minimal erythema dose), 2주째는 2 MED, 3주째는 3 MED, 4주부터 16주까지는 4 MED로 조사하였다. 사육하는 동안 매주 체중을 측정하였고, 등 피부 부위의 사진촬영을 실시하였다. 실험사육 마지막 날 실험동물을 6시간 공복시키고 마취한 상태에서 혈액과 등 피부조직을 채취하였다.Six-week-old female hairless mice (SKH-1 hairless mice) used in this example were purchased from Central Experimental Animal Co., Ltd. (Seoul, Korea) and used for 1 week. Experimental animals were divided into 5 groups and 10 animals were assigned to each group and used for the experiment. The experimental group was divided into the normal control group (normal), the ultraviolet group (UV), and the UV group irradiated with rice bran extract (0.1% diet or 0.5% diet) or dandelion extract. Feed and water were freely ingested during the breeding period, and the temperature was maintained at 23 ± 2 ℃, the humidity was maintained at 40-60%, and the photoperiod and dark cycle were adjusted to 12 hours daily. The rice bran extract ingestion group supplied the diet prepared by adding 0.1% or 0.5% of rice bran extract prepared by the method of Preparation Example for 16 weeks, and the dandelion extract intake group was added to the diet containing 0.5% of the dandelion extract prepared by the above method. Breeding weekly. The diet was fed with water at 2 pm daily, and the dietary intake was measured daily. During the breeding period, ultraviolet B (UVB) was irradiated to the back of the hairless mice three times a week, and the amount of ultraviolet radiation was 1 MED (1 MED = 0.5 J /
실험예 3. 자외선 조사 무모생쥐의 피부조직의 수분함량 변화(도 1의 a, b)Experimental Example 3. Changes in moisture content of skin tissues of UV-radiated hairless mice (Fig. 1, a, b)
쌀겨추출물의 피부보습 효과를 확인하기 위하여 무모 생쥐 등 피부의 수분 함량을 피부 커패시턴스 측정 (Skin-O-Mat, Cosmomed, Germany)으로 평가하고 1 시간 동안 20 ℃ (±2 ℃) 및 50 % (±5 %) 습도로 유지시켰다. 추가 실험을 위해 안락사 전날 5 개 또는 6 개의 연속 측정 값에 대한 표준 편차가 0.1 미만인 경우 마지막 5 개 측정 값의 평균을 각 동물의 수분 값으로 하였다.In order to confirm the skin moisturizing effect of rice bran extract, the moisture content of skin such as hairless mice was evaluated by skin capacitance measurement (Skin-O-Mat, Cosmomed, Germany) and 20 ℃ (± 2 ℃) and 50% (±) for 1 hour. 5%) was kept at humidity. For further experiments, if the standard deviation for five or six consecutive measurements on the day before euthanasia was less than 0.1, the average of the last five measurements was taken as the water value of each animal.
자외선 조사, 쌀겨추출물 및 민들레추출물 섭취는 무모 생쥐의 체중 및 식이섭취량에 유의한 영향을 미치지 않았다(도 1a). 16주 동안 자외선을 조사받은 +UVB 대조군은 자외선을 조사받지 않은 정상군(-UVB)에 비해 피부조직의 수분함유량은 유의하게 감소한 한편, 홍반지수는 유의하게 증가하였다(도 1b 및 1c). 쌀겨추출물을 섭취시킨 군의 경우 같은 세기의 UV가 조사되었음에도 불구하고 +UVB 대조군에 비해 수분함유량이 20% 유의하게 증가하였고, 특히 쌀겨 추출물(0.5%)을 섭취한 군에서는 수분 함유량이 유의적으로 높게 나타났다(도 1b).Ultraviolet irradiation, rice bran extract and dandelion extract intake did not significantly affect the weight and dietary intake of hairless mice (FIG. 1A). In the + UVB control group irradiated with ultraviolet rays for 16 weeks, the water content of the skin tissue was significantly decreased while the erythema index was significantly increased compared to the normal group (-UVB) which was not irradiated with ultraviolet rays (FIGS. 1B and 1C). In the group of rice bran extract, the moisture content was significantly increased by 20% compared to the + UVB control group, even though UV was irradiated at the same intensity, especially in the group of rice bran extract (0.5%). It was high (Fig. 1b).
실험예 4. 자외선 조사 무모생쥐의 피부두께 변화(도 2의 a, b)Experimental Example 4. Changes in skin thickness of UV-radiated hairless mice (Figs. 2A and 2B)
자외선 등에 의한 광노화가 진행되면 피부 진피층을 보호하기 위해 각질층의 형성이 증가하여 피부가 두꺼워지고, 따라서 자외선 조사에 의해 피부 표피층의 두께가 두꺼워졌다는 것은 그만큼 광노화에 의한 피부 손상이 크다는 것을 의미한다(Gail J Molecular mechanism of skin ageing Mech Ageing Dev 123: 801-810, 2002). 이에 광노화에 의한 피부손상을 확인하기 위하여 실험사육 마지막날 무모생쥐의 등 피부 조직을 적출하여 10% 중성 포르말린에 고정한 다음, 헤마톡실린 및 에오신(H&E)으로 염색한 뒤 형광 현미경 (Nikon Eclipse Ti-S, Tokyo, Japan)을 이용하여 관찰하고 이미지를 Metamorph (Molecular Devices, Danville, PA) 소프트웨어로 분석 하였다.As photoaging progresses due to ultraviolet rays, the formation of the stratum corneum increases to protect the dermal layer of the skin, thereby thickening the skin. Therefore, the thickness of the skin epidermal layer increased by ultraviolet irradiation means that the skin damage caused by photoaging is large. J Molecular mechanism of skin ageing Mech Ageing Dev 123: 801-810, 2002). To confirm the skin damage caused by photoaging, the back skin tissues of hairless mice were extracted and fixed in 10% neutral formalin on the last day of experimental breeding, and stained with hematoxylin and eosin (H & E), followed by fluorescence microscopy (Nikon Eclipse Ti-). S, Tokyo, Japan) and images were analyzed with Metamorph (Molecular Devices, Danville, PA) software.
그 결과, +UVB 대조군은 자외선을 조사받지 않은 정상군(-UVB)에 비해 피부두께가 유의하게 증가하였고 쌀겨추출물을 섭취시킨 군은 +UVB 대조군에 비해 피부두께가 42.6% 유의하게 감소하였음이 확인되었다(도 2a). 피부조직의 H&E 염색을 통해 무모생쥐의 피부 표피층 두께를 관찰한 결과에서도 +UVB 대조군은 자외선을 조사받지 않은 정상군(-UVB)에 비해 피부 표피층이 비후해진 것이 관찰되었고, 쌀겨추출물 섭취군의 경우 자외선 조사에 의해 비후 해진 표피층의 두께가 현저히 감소되었음이 확인되었다(도 2b).As a result, the + UVB control group showed a significant increase in skin thickness compared to the normal group (-UVB), which was not irradiated with UV light, and the group treated with rice bran extract showed a 42.6% decrease in skin thickness compared to the + UVB control group. (FIG. 2A). The skin epidermal layer thickness of hairless mice by H & E staining of skin tissues also showed that the + UVB control group thickened the skin epidermal layer compared to the normal group (-UVB) without UV irradiation. It was confirmed that the thickness of the epidermal layer thickened by ultraviolet irradiation was significantly reduced (FIG. 2B).
실험예 5. 자외선 조사 무모생쥐의 피부주름 생성변화(도 3의 a, b)Experimental Example 5 Changes in Skin Wrinkle Production of Ultraviolet Irradiated Hairless Mice (FIGS. 3A and 3B)
쌀겨추출물의 섭취가 피부주름의 형성정도에 미치는 영향을 평가하기 위하여 실험동물의 등피부 부위를 사진 촬영하였다. 16주 동안 자외선 조사를 실시한 무모 생쥐의 피부를 실리콘 고무로 성형하여 주름의 형성 정도를 측정하였다. 무모 생쥐의 등 부분에 구멍이 있는 디스크를 부착하고 실리콘 폴리머 (Silfo, Flexico Developments LDT, England) 시약을 혼합하여 무모 생쥐의 등 지면에 얇게 펴 바르고 완전히 건조시킨 다음 조심스럽게 떼어내어 모사판을 제작하였다. 제작한 모사판은 Daegu Technopark (대구, 한국)에 의뢰하여 분석하였으며, 피부주름 곡선을 피부주름 측정 장치 (Visioline VL650, Courage-Khazaka Electronic)를 사용하여 평가하였고, 다양한 피부 특성을 평행 광원 및 b/w CMOS 카메라를 사용하여 분석하였다.To evaluate the effect of intake of rice bran extract on the formation of skin wrinkles, photographs of the back skin of experimental animals were taken. The skin of hairless mice subjected to ultraviolet irradiation for 16 weeks was molded with silicone rubber to measure the extent of wrinkle formation. A disk with a hole was attached to the back of the hairless mouse, and a silicone polymer (Silfo, Flexico Developments LDT, England) reagent was mixed, spreaded thinly on the back of the hairless mouse, completely dried, and carefully removed to prepare a replica plate. . The simulated plate was commissioned by Daegu Technopark (Daegu, Korea) and the skin wrinkle curves were evaluated using a skin wrinkle measuring device (Visioline VL650, Courage-Khazaka Electronic). Analyze using w CMOS camera.
16주 동안 UVB에 반복적으로 노출된 +UVB 대조군은 자외선을 조사받지 않은 정상군(-UVB)에 비해 다수의 굵고 깊게 패인 주름과 함께 잔주름형성이 비정상적으로 증가된 것을 육안 상으로 관찰할 수 있었으며, 쌀겨추출물 섭취군의 경우 +UVB 대조군에 비해 주름의 굵기와 깊이가 현저히 감소한 것을 확인하였고, 나아가 고농도의 쌀겨추출물 섭취군은 자외선을 조사받지 않은 -UVB군에서 관찰된 피부상태와 유사하게 개선된 것을 확인하였다(도 3a 및 b). 이와 같은 쌀겨추출물의 주름개선 효능은 같은 농도의 민들레추출물에서 관찰된 주름개선효능보다 우수하였다.The + UVB control group, which was repeatedly exposed to UVB for 16 weeks, was visually observed to have an abnormal increase in fine wrinkle formation along with a number of coarse and deeply creased wrinkles compared to the normal group (-UVB), which was not irradiated with UVB. In the rice bran extract intake group, the thickness and depth of the wrinkles were significantly reduced compared to the + UVB control group. Furthermore, the rice bran extract intake group showed an improvement similar to the skin condition observed in the -UVB group that was not irradiated with ultraviolet rays. It was confirmed (FIGS. 3A and B). The antiwrinkle effect of the rice bran extract was superior to the antiwrinkle effect observed in the same concentration of dandelion extract.
실험예 6. 쌀겨추출물의 자외선에 의한 COX-2 발현 억제 효과 확인(도 4의 a, b)Experimental Example 6. Confirmation of the inhibitory effect of COX-2 expression by ultraviolet light of rice bran extract (a, b of Figure 4)
자외선을 조사하면 피부조직에서 콜라겐 분해효소인 MMP-13(collagenase)이 증가되고 이는 피부 노화를 매개한다. 또한, 자외선 조사에 의해 유도되는 COX-2의 발현은 염증반응에 관여한다. 자외선에 의한 COX-2 및 MMP-13 발현에 대한 쌀겨추출물의 효과를 알아보기 위하여 무모 생쥐의 피부조직을 용해 완충액과 스테인레스 스틸 비드가 들어있는 2 mL microcentrifuge tube에 넣고 TissueLyser II (Qiagen, Valencia, CA, USA)에서 20 Hz에서 2 분간 2 회 균질화시켰다. 조직 균질액을 20분 동안 12,000 rpm으로 원심 분리 하였다. 단백질을 원심 분리 후 상층액을 취하여 DC Protein Assay kit(Bio-Rad Laboratories)를 사용하여 단백질의 농도를 측정하였다. 피부조직 추출물은 SDS-PAGE 전기영동으로 단백질을 분리하였다. 이를 나일론 멤브레인에 옮긴 후 항체를 이용하여 원하는 단백질을 분리하였다. 이를 형광 현미경 (Nikon Eclipse Ti-S, Tokyo, Japan)을 사용하여 표피의 두께와 MMP-13 및 COX-2 발현을 시각화하고 이미지를 Metamorph (Molecular Devices, Danville, PA) 소프트웨어로 분석 하였다.UV irradiation increases collagen degrading enzyme MMP-13 (collagenase) in the skin tissue, which mediates skin aging. In addition, expression of COX-2 induced by ultraviolet irradiation is involved in the inflammatory response. To investigate the effect of rice bran extract on the expression of COX-2 and MMP-13 by UV light, skin tissues of hairless mice were placed in a 2 mL microcentrifuge tube containing lysis buffer and stainless steel beads. TissueLyser II (Qiagen, Valencia, CA) , USA), and homogenized twice at 20 Hz for 2 minutes. Tissue homogenates were centrifuged at 12,000 rpm for 20 minutes. The protein was centrifuged and the supernatant was taken to measure the protein concentration using a DC Protein Assay kit (Bio-Rad Laboratories). Skin tissue extracts were separated by SDS-PAGE electrophoresis. After transferring it to a nylon membrane, the desired protein was isolated using an antibody. The fluorescence microscope (Nikon Eclipse Ti-S, Tokyo, Japan) was used to visualize epidermal thickness and MMP-13 and COX-2 expression, and images were analyzed with Metamorph (Molecular Devices, Danville, PA) software.
그 결과, 도 4a에서 알 수 있듯이, +UVB 대조군은 자외선 조사에 의해 COX-2 및 MMP-13의 발현이 증가하고, 이렇게 증가된 COX-2 및 MMP-13 발현이 쌀겨추출물 섭취군에서는 농도 의존적으로 감소함을 확인할 수 있었으며, 이는 조직 염색에서도 동일하게 나타났다(도 4b).As a result, as can be seen in Figure 4a, the + UVB control is increased in the expression of COX-2 and MMP-13 by ultraviolet irradiation, and this increased COX-2 and MMP-13 expression is concentration-dependent in the rice bran extract intake group It was confirmed that the decrease, which was the same in tissue staining (Fig. 4b).
실험예 7. MMP-13 및 COX-2 발현 억제 기작 확인(도 5의 a, b)Experimental Example 7. Confirmation of the mechanism of suppression of MMP-13 and COX-2 expression (FIG. 5 a, b)
MAPK 신호는 자외선에 의해 유도되는 MMP-13 및 COX-2 발현에 중심 역할을 하는 것으로 알려져있다. 이에, 쌀겨추출물이 마우스 피부 조직에서 자외선에 의해 유도된 MAPK 신호 케스케이드를 차단하여 MMP-13 및 COX-2 생성을 감소시키는지 여부를 확인하기 위하여, JNK1/2, ERK1/2 및 p38 MAPK 단백질의 인산화에 대한 쌀겨추출물의 영향을 검토하였다.MAPK signals are known to play a central role in UV-induced MMP-13 and COX-2 expression. Thus, to determine whether rice bran extract blocks the UV-induced MAPK signal cascade in mouse skin tissues to reduce MMP-13 and COX-2 production, the JNK1 / 2, ERK1 / 2 and p38 MAPK proteins The effect of rice bran extract on phosphorylation was examined.
전체 JNK1/2, ERK1/2 및 p38 MAPK 단백질 인산화 수준을 웨스턴 블럿 분석으로 측정한 결과, 도 5a 및 5b에 도시된 바와 같다. 즉, +UVB 대조군에서 ERK1/2, JNK1/2, 및 p38 MAPK 단백질 인산화가 유도된 반면, 쌀겨추출물 섭취군에서는 UVB-유도 ERK1/2, JNK1/2, 및 p38 MAPK 단백질 인산화가 감소되었다. 따라서, 쌀겨추출물은 ERK1/2, JNK1/2 및 p38 MAPK 경로 억제를 통해 UVB-유도 MMP-1, COX-2 발현을 유의하게 억제한다는 것을 암시한다.Total JNK1 / 2, ERK1 / 2 and p38 MAPK protein phosphorylation levels were determined by Western blot analysis, as shown in FIGS. 5A and 5B. That is, ERK1 / 2, JNK1 / 2, and p38 MAPK protein phosphorylation was induced in the + UVB control group, whereas UVB-induced ERK1 / 2, JNK1 / 2, and p38 MAPK protein phosphorylation were decreased in the rice bran extract group. Thus, it suggests that rice bran extract significantly inhibits UVB-induced MMP-1, COX-2 expression through inhibition of the ERK1 / 2, JNK1 / 2 and p38 MAPK pathways.
제조예 1. 건강기능식품의 제조 Preparation Example 1 Preparation of Health Functional Food
하기 조성으로, 쌀겨 추출물을 함유하는 건강기능식품을 제조하였다.With the following composition, a dietary supplement containing rice bran extract was prepared.
1-1. 건강기능식품의 제조1-1. Preparation of health functional food
쌀겨 추출물 1000 ㎎, 비타민 혼합물 적량, 비타민 A 아세테이트 1.0 ㎎, 비타민 E 0.13 ㎎, 비타민 B1 0.15 ㎎, 비타민 B2 0.5 ㎎, 비타민 B6 0.2 ㎍, 비타민 B12 10 ㎎, 비타민 C 10 ㎍, 비오틴 1.7 ㎎, 니코틴산아미드 50 ㎍, 엽산 0.5 ㎎ 판토텐산 칼슘 적량, 무기질 혼합물 적량, 황산제1철 1.75 ㎎, 산화아연 0.82 ㎎ 탄산마그네슘 25.3 ㎎, 제1인산칼륨 15 ㎎, 제2인산칼륨 55 ㎎, 구연산칼륨 90 mg, 탄산칼슘 100 mg, 염화마그네슘 24.8 mgRice bran extract 1000 mg, vitamin mixture amount, vitamin A acetate 1.0 mg, vitamin E 0.13 mg, vitamin B1 0.15 mg, vitamin B2 0.5 mg, vitamin B6 0.2 μg,
1-2. 건강 음료의 제조1-2. Manufacture of healthy drinks
쌀겨 추출물 1000 ㎎, 구연산 1000 ㎎, 올리고당 100 g, 매실농축액 2 g, 타우린 1 g, 정제수 적량Rice bran extract 1000 mg, citric acid 1000 mg, oligosaccharide 100 g, plum concentrate 2 g, taurine 1 g, purified water
1-3. 정제의 제조1-3. Manufacture of tablets
쌀겨 추출물 1000 ㎎, 옥수수 전분 100 ㎎, 유당 100 ㎎, 스테아린산 마그네슘 2 ㎎Rice bran extract 1000 mg,
1-4. 캡슐제의 제조1-4. Preparation of Capsule
쌀겨 추출물 1000 ㎎, 옥수수 전분 100 ㎎, 유당 100 ㎎, 스테아린산 마그네슘 2 ㎎Rice bran extract 1000 mg,
1-5. 환의 제조1-5. Manufacture of rings
쌀겨 추출물 1 g, 유당 1.5 g, 글리세린 1 g, 자일리톨 0.5 g1 g of rice bran extract, 1.5 g of lactose, 1 g of glycerin, 0.5 g of xylitol
1-6. 과립의 제조1-6. Preparation of Granules
쌀겨 추출물 1000 ㎎, 대두추출물 50 ㎎, 포도당 200 ㎎, 전분 600 ㎎Rice bran extract 1000 mg, soy extract 50 mg,
제조예 2. 피부외용 연고의 제조Preparation Example 2 Preparation of Skin Ointment
쌀겨 추출물 0.5 중량%, 디에틸 세바케이트 8.0 중량%, 경납 5.0 중량%, 폴리옥시에틸렌올레일에테르 포스페이트 6.0 중량%, 벤조산 나트륨 적량Rice bran extract 0.5%, diethyl sebacate 8.0% by weight, light lead 5.0% by weight, polyoxyethylene oleyl ether phosphate 6.0% by weight, appropriate amount of sodium benzoate
제조예 3. 화장품의 제조Preparation Example 3 Preparation of Cosmetics
3-1. 유연 화장수의 제조3-1. Preparation of Flexible Lotion
쌀겨 추출물 0.1 중량%, 에탄올 10.0 중량%, 폴리라우린산 폴리옥시에틸렌 소르비탄 1.0 중량%, 파라옥시안식향산메칠 0.2 중량%, 글리세린 5.0 중량%, 1,3-부틸렌글리콜 6.0 중량%, 향 적량, 색소 적량Rice bran extract 0.1%, ethanol 10.0%, polylauric acid polyoxyethylene sorbitan 1.0%, paraoxybenzoic acid methyl 0.2%, glycerin 5.0%, 1,3-butylene glycol 6.0%, fragrance amount Pigment amount
3-2. 영양 크림의 제조3-2. Manufacture of nutritional cream
쌀겨 추출물 0.2 중량%, 스테아린산 15.0 중량%, 세탄올 1.0 중량%, 수산화칼륨 0.7 중량%, 글리세린 5.0 중량%, 프로필렌글리콜 3.0 중량%, 방부제 적량, 향 적량, 잔부의 정제수Rice bran extract 0.2% by weight, stearic acid 15.0% by weight, cetanol 1.0% by weight, potassium hydroxide 0.7% by weight, glycerin 5.0% by weight, propylene glycol 3.0% by weight, preservative amount, fragrance amount, balance purified water
3-3. 팩의 제조3-3. Manufacture of pack
쌀겨 추출물 0.05 중량%, 글리세린 5.0 중량%, 프로필렌글리콜 4.0 중량%, 폴리비닐알코올 15.0 중량%, 에탄올 8.0 중량%, 폴리옥시에틸렌올레일에칠 1.0 중량%, 파라옥시안식향산메칠 0.2 중량%, 색소 적량, 향 적량Rice bran extract 0.05%, glycerin 5.0%, propylene glycol 4.0%, polyvinyl alcohol 15.0%, ethanol 8.0%, polyoxyethylene oleyl ethyl 1.0%, paraoxybenzoic acid methyl 0.2%, pigment Incense
Claims (10)
상기 단계에서 얻어진 쌀겨 추출물을 65℃ 이하의 온도에서 13±2 Brix가 되도록 농축하는 단계;
상기 단계에서 얻어진 쌀겨 추출물 농축액 100 중량부에 대하여 Tween 20 1.2 중량부, 카제인 나트륨 3 중량부, 토코페롤 0.01 중량부를 혼합하는 단계; 및
상기 단계에서 얻어진 혼합물을 80±3℃에서 15분 동안 살균시키고, 입구온도 160℃, 출구온도 90℃, 유속 8-10 L/h 조건에서 분무 건조하는 단계를 포함하는 피부 주름 개선용 식품 조성물의 제조방법.Extracting rice bran with ethanol at 40 ° C. for 8 hours;
Concentrating the rice bran extract obtained in the above step to 13 ± 2 Brix at a temperature of less than 65 ℃;
Mixing 1.2 parts by weight of Tween 20, 3 parts by weight of sodium casein, and 0.01 parts by weight of tocopherol based on 100 parts by weight of the rice bran extract concentrate obtained in the step; And
Sterilizing the mixture obtained in the above step at 80 ± 3 ℃ for 15 minutes, spray drying at the inlet temperature 160 ℃, outlet temperature 90 ℃, flow rate 8-10 L / h conditions of the food composition for improving skin wrinkles Manufacturing method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170139139A KR102032830B1 (en) | 2017-10-25 | 2017-10-25 | Fuctional food improving skin condition comprising rice bran extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170139139A KR102032830B1 (en) | 2017-10-25 | 2017-10-25 | Fuctional food improving skin condition comprising rice bran extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190053309A KR20190053309A (en) | 2019-05-20 |
KR102032830B1 true KR102032830B1 (en) | 2019-10-17 |
Family
ID=66678617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170139139A KR102032830B1 (en) | 2017-10-25 | 2017-10-25 | Fuctional food improving skin condition comprising rice bran extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102032830B1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004075661A (en) * | 2002-06-18 | 2004-03-11 | Shiseido Co Ltd | Skin external agent characterized with epidermis basement membrane care, epidermis basement membrane structure formation-accelerating agent |
KR101367961B1 (en) | 2012-01-02 | 2014-02-27 | 손정화 | Compositoin for Improving Atopic Dermatitis |
-
2017
- 2017-10-25 KR KR1020170139139A patent/KR102032830B1/en active IP Right Grant
Non-Patent Citations (2)
Title |
---|
{CJ이너비/바이탈뷰티}서인영도 먹는 수분 트리트먼트 / 이너뷰티식품, 네이버 블로그(http://lemorce.blog.me/60150835685), (2011.12.24.) 1부.* |
김미혜, 미강 추출물의 항산화, 항염작용 및 화장품의 응용에 관한 연구, 박사학위논문, (2011년 11월) 1부.* |
Also Published As
Publication number | Publication date |
---|---|
KR20190053309A (en) | 2019-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102190896B1 (en) | Composition for skin cell regeneration, anti-wrinkle, anti-inflammation, or skin whitening | |
KR101776071B1 (en) | Composition containing red sword bean extract for anti-aging and whitening | |
KR101715294B1 (en) | Composition having effects of skin moisturizing, exfoliating, improving skin elasticity, inhibiting erythema, anti-wrinkle or improving skin photoaging comprising diosmin or salt thereof | |
KR101721022B1 (en) | Composition for comprising adipic acid for improving skin wrinkle or enhancing skin elasticity | |
KR101768626B1 (en) | Skin whitening composition comprising an extract obtained from carthamus tinctorius l. | |
JP2014105210A (en) | Composition containing white tea extract having activity of inhibiting skin crease formation and ameliorating crease | |
KR20180040756A (en) | Skin whitening composition comprising an extract of coixlachryma-jobi var. mayuen | |
JP2002068993A (en) | Epidermal keratinizing cell propagation-accelerating agent, beautifying food and skin cosmetic | |
KR101447007B1 (en) | Composition for antiaging comprising the extract of Dipterocarpus obtusifolius Teijsm. Ex Miq. as an active ingredient | |
KR102032830B1 (en) | Fuctional food improving skin condition comprising rice bran extract | |
KR20150113632A (en) | Composition for improving skin conditions and method for improving skin conditions using the same | |
KR20150041968A (en) | Composition for the prevention and treatment of inflammatory diseases containing the solvent fractions of Phaeodactylum tricornutum as an active ingredient | |
KR102212343B1 (en) | Composition for skin anti-aging or moisturization comprising extract of marian plum | |
KR101579500B1 (en) | Skin whitening composition comprising an extract obtained from roots of coix lachryma-jobi var. mayuen | |
KR102106440B1 (en) | Composition for improving skin condition comprising blueberry and black rice extract fermented lactic acid bacteria | |
JP4413272B1 (en) | Hyaluronic acid production promoter | |
KR101256222B1 (en) | Method for removing the pigment of Red beet extract using irradiation | |
KR100921971B1 (en) | A composition comprising Chamaenerion angustifolium extract as an active ingredient | |
KR20160068316A (en) | Skin whitening composition comprising an extract obtained from phellodendron amurense rupr. | |
KR101661423B1 (en) | anti-oxidant and anti-inflammation composition extracted from Isodon excisus, and its extracting method | |
KR101988988B1 (en) | Composition for skin cell regeneration, anti-wrinkle, antioxidant and skin whitening | |
JP7307172B2 (en) | Composition for skin whitening containing allulose as an active ingredient | |
KR102114894B1 (en) | Composition for antioxidant, anti-imflamation, and skin whitening | |
KR101701502B1 (en) | Composition having effects of skin moisturizing, exfoliating, improving skin elasticity, inhibiting erythema, anti-wrinkle or improving skin photoaging comprising decanal or salt thereof | |
KR101702493B1 (en) | Composition for comprising borneol for moisturizing and improving skin wrinkle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) |